Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 221,165 | 96,383 | 234,195 | 147,159 | 90,932 |
| Marketable Securities | 127,110 | 179,225 | 128,599 | 118,425 | 118,428 |
| Receivables | 246,179 | 194,883 | 231,072 | 233,302 | 189,368 |
| Inventories | 132,406 | 107,521 | 100,123 | 103,276 | 97,615 |
| TOTAL | $765,745 | $615,019 | $739,013 | $653,201 | $541,938 |
| Non-Current Assets | |||||
| PPE Net | 74,559 | 77,964 | 75,570 | 36,674 | 37,091 |
| Intangibles | 927,803 | 945,040 | 955,701 | 1,148,385 | 1,175,578 |
| Other Non-Current Assets | 42,333 | 61,424 | 71,227 | 26,283 | 26,783 |
| TOTAL | $1,044,695 | $1,084,428 | $1,102,498 | $1,211,342 | $1,239,452 |
| Total Assets | $1,810,440 | $1,699,447 | $1,841,511 | $1,864,543 | $1,781,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 13,334 | 13,315 | 99,048 |
| Accounts payable and accrued liabilities | 10,120 | 8,695 | 17,693 | 18,166 | 12,232 |
| Accrued Expenses | 105,431 | 79,978 | 99,762 | 74,317 | 84,101 |
| TOTAL | $116,393 | $91,919 | $130,789 | $109,384 | $199,512 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,495,998 | 1,494,380 | 1,492,766 | 1,491,156 | 1,147,129 |
| Deferred Revenues | 842 | 3,246 | N/A | 3,586 | 4,131 |
| Other Non-Current Liabilities | 44,763 | 45,045 | 48,158 | 135,190 | 135,551 |
| TOTAL | $1,543,014 | $1,541,678 | $1,540,924 | $1,658,168 | $1,288,707 |
| Total Liabilities | $1,659,407 | $1,633,597 | $1,671,713 | $1,767,552 | $1,488,219 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,921 | 131,680 | 135,367 | 135,213 | 137,779 |
| Common Shares | 132 | 132 | 135 | 135 | 138 |
| Retained earnings | 140,448 | 65,694 | 143,217 | 85,515 | 23,881 |
| Other shareholders' equity | -1,615 | 24 | -922 | -1,836 | -2,017 |
| TOTAL | $151,033 | $65,850 | $169,798 | $96,991 | $293,171 |
| Total Liabilities And Equity | $1,810,440 | $1,699,447 | $1,841,511 | $1,864,543 | $1,781,390 |